Variant report
Variant | nsv968229 |
---|---|
Chromosome Location | chr5:99729149-99740034 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:28)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:28 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr5:99734563-99734858 | K562 | blood: | n/a | chr5:99734716-99734725 chr5:99734716-99734725 chr5:99734716-99734725 chr5:99734716-99734727 chr5:99734714-99734727 chr5:99734714-99734727 chr5:99734716-99734725 |
2 | CTCF | chr5:99734932-99734978 | ProgFib | skin: | n/a | n/a |
3 | CTCF | chr5:99733797-99733864 | Spleen_OC | spleen: | n/a | n/a |
4 | CTCF | chr5:99733513-99733538 | MCF-7 | breast: | n/a | n/a |
5 | CTCF | chr5:99733487-99733594 | MCF-7 | breast: | n/a | n/a |
6 | FOXA1 | chr5:99737255-99737445 | T-47D | breast: | n/a | chr5:99737322-99737337 chr5:99737357-99737372 |
7 | FOXA2 | chr5:99737262-99737499 | A549 | lung: | n/a | n/a |
8 | GATA2 | chr5:99730840-99731086 | K562 | blood: | n/a | n/a |
9 | MAFF | chr5:99738731-99738983 | HepG2 | liver: | n/a | n/a |
10 | MAFK | chr5:99732365-99732541 | HepG2 | liver: | n/a | chr5:99732486-99732497 chr5:99732485-99732501 chr5:99732486-99732497 chr5:99732484-99732498 chr5:99732485-99732496 chr5:99732485-99732496 |
11 | MAFK | chr5:99738713-99738949 | HepG2 | liver: | n/a | n/a |
12 | MAFK | chr5:99738707-99738907 | HepG2 | liver: | n/a | n/a |
13 | MAFK | chr5:99738612-99738628 | H1-hESC | embryonic stem cell: | n/a | n/a |
14 | MYC | chr5:99738707-99738862 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | NRF1 | chr5:99739199-99739200 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | PAX5 | chr5:99730810-99731201 | GM12878 | blood: | n/a | n/a |
17 | PBX3 | chr5:99729597-99729733 | GM12878 | blood: | n/a | n/a |
18 | POLR2A | chr5:99738233-99738386 | K562 | blood: | n/a | n/a |
19 | POLR2A | chr5:99737041-99737219 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | POU2F2 | chr5:99730885-99731067 | GM12878 | blood: | n/a | n/a |
21 | SP1 | chr5:99730815-99731094 | GM12878 | blood: | n/a | n/a |
22 | SPI1 | chr5:99734570-99734747 | K562 | blood: | n/a | chr5:99734655-99734668 chr5:99734698-99734705 chr5:99734657-99734666 |
23 | SPI1 | chr5:99734571-99734778 | GM12878 | blood: | n/a | chr5:99734655-99734668 chr5:99734698-99734705 chr5:99734657-99734666 |
24 | SPI1 | chr5:99734537-99734816 | GM12891 | blood: | n/a | chr5:99734655-99734668 chr5:99734698-99734705 chr5:99734657-99734666 |
25 | SPI1 | chr5:99732893-99733207 | GM12891 | blood: | n/a | n/a |
26 | SPI1 | chr5:99732888-99733205 | GM12878 | blood: | n/a | n/a |
27 | SPI1 | chr5:99732942-99733147 | GM12878 | blood: | n/a | n/a |
28 | SPI1 | chr5:99732826-99733189 | GM12891 | blood: | n/a | n/a |
No data |
No data |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FAM174A-1 | chr5:99737145-99737487 | XLOC_004490 |
2 | lnc-FAM174A-1 | chr5:99737164-99737487 | XLOC_004490 |
3 | lnc-FAM174A-1 | chr5:99737280-99737487 | NONHSAT103000 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000249787 | TF binding region |
DMD | miRNA target sites |
FAM81A | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544575352 | chr5:99732461-99732462 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs556601601 | chr5:99732509-99732510 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs574934690 | chr5:99732522-99732523 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs189240084 | chr5:99732846-99732847 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs543888417 | chr5:99732862-99732863 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs368169408 | chr5:99732879-99732880 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs561335683 | chr5:99732906-99732907 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs528914282 | chr5:99732972-99732973 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs200838077 | chr5:99733040-99733041 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs201860906 | chr5:99733085-99733086 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs559343327 | chr5:99733862-99733863 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs532830021 | chr5:99734402-99734403 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs2927011 | chr5:99734444-99734445 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs563603653 | chr5:99734458-99734459 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs181346014 | chr5:99734476-99734477 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370570210 | chr5:99734539-99734540 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs568424540 | chr5:99734599-99734600 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs529394773 | chr5:99734608-99734609 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs183603891 | chr5:99734609-99734610 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs547614508 | chr5:99734614-99734615 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs372290121 | chr5:99734651-99734652 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs566047987 | chr5:99734666-99734667 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs539472994 | chr5:99734701-99734702 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs557999177 | chr5:99734718-99734719 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs570028785 | chr5:99734740-99734741 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs367703390 | chr5:99734756-99734757 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs537208436 | chr5:99734778-99734779 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs551426529 | chr5:99734819-99734820 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs555929657 | chr5:99734820-99734821 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs574197956 | chr5:99734827-99734828 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs541113002 | chr5:99734840-99734841 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs552829146 | chr5:99734857-99734858 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs374815708 | chr5:99734875-99734876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs577690956 | chr5:99734879-99734880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188316795 | chr5:99734934-99734935 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs563542636 | chr5:99734950-99734951 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs530838132 | chr5:99734991-99734992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs56060625 | chr5:99735045-99735046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560100435 | chr5:99735078-99735079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542413132 | chr5:99735091-99735092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs369103621 | chr5:99735104-99735105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561135703 | chr5:99735173-99735174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs56031114 | chr5:99735174-99735175 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs13167564 | chr5:99735178-99735179 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs202177611 | chr5:99735186-99735187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs71586523 | chr5:99735203-99735204 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs149781377 | chr5:99735220-99735221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550279255 | chr5:99735225-99735226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs551369171 | chr5:99735259-99735260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181072538 | chr5:99735263-99735264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:99734400-99734800 | Active TSS | Monocytes-CD14+_RO01746 | blood |
2 | chr5:99734400-99735400 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr5:99736800-99738200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr5:99737000-99738000 | Enhancers | Fetal Lung | lung |
5 | chr5:99737200-99738200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr5:99737400-99738000 | Active TSS | Fetal Brain Male | brain |
7 | chr5:99738000-99738800 | Weak transcription | Fetal Brain Male | brain |
8 | chr5:99738000-99740000 | Weak transcription | Fetal Lung | lung |
9 | chr5:99738200-99739200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr5:99739200-99739400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr5:99740000-99740600 | Enhancers | Fetal Lung | lung |